Explore comprehensive CDMO services offered by Oxford Biomedica PLC, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Oxford Biomedica PLC enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: United Kingdom
Description: Oxford Biomedica PLC is a British-based public company that is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, particularly the development and manufacturing of viral vectors. It is listed on the London Stock Exchange (LSE: OXB) and is headquartered in Oxford, UK. The company offers its proprietary platform technologies, such as the LentiVector platform and inAAVate, to pharmaceutical and biotechnology companies to help them develop and scale up their gene and cell therapy products.
